8-K: Adagio Medical Sets 2026 Annual Meeting Date
Annual Meeting Announcement
Adagio Medical Holdings, Inc. has scheduled its 2026 Annual Meeting of Stockholders for June 16, 2026.
Summary
- The company has officially scheduled its 2026 Annual Meeting of Stockholders for June 16, 2026.
- The record date for determining stockholders eligible to vote is set for the close of business on April 24, 2026.
- Stockholder proposals and director nominations must be received by the company no later than April 30, 2026, to be considered timely.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing that does not impact the company's financial or operational outlook.
Positives
- Clear communication regarding the timeline for the upcoming annual meeting provides transparency for shareholders.
- Adherence to regulatory timelines ensures orderly corporate governance processes.
Negatives
- The deadline for stockholder proposals is relatively tight, set for only 10 days after the public announcement of the meeting date.
Risks
- Failure by stockholders to meet the April 30, 2026, deadline will result in the exclusion of their proposals or nominations from the 2026 Annual Meeting agenda.
Future Outlook
The company will provide further details regarding the time and location of the 2026 Annual Meeting in its forthcoming definitive proxy statement.
Industry Context
StockSavvy.ai notes that this filing is a standard administrative procedure for publicly traded companies to ensure compliance with SEC proxy rules and internal bylaws ahead of annual general meetings.
Comparison to Industry Standards
- The timeline provided is consistent with standard corporate governance practices for Nasdaq-listed companies.
- The 10-day window for nominations following the announcement is a specific requirement of the company's bylaws, which is common for Delaware-incorporated entities.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Meeting Scheduling | Setting of the 2026 Annual Meeting date and associated deadlines for shareholder action. | 2026-04-20 | Establishes the timeline for shareholder participation in corporate governance. |
Stakeholder Impact
- Shareholders must act by April 30, 2026, if they wish to submit proposals or nominate directors.
Next Steps
- File the definitive proxy statement with the SEC.
- Receive and process any timely stockholder proposals or director nominations by April 30, 2026.
- Hold the 2026 Annual Meeting of Stockholders on June 16, 2026.
Key Dates
| Date | Description |
|---|---|
| 2026-04-20 | Date of the 8-K filing announcing the annual meeting details. |
| 2026-04-24 | Record date for stockholders entitled to notice and to vote. |
| 2026-04-30 | Deadline for stockholder proposals and director nominations. |
| 2026-06-16 | Date of the 2026 Annual Meeting of Stockholders. |
Keywords
Adagio Medical, ADGM, Annual Meeting, Proxy Statement, Corporate Governance, Shareholder Proposals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.